Superpotent Pills Trigger Recall: Blood Pressure Meds Affected

Viatris has initiated a recall of 21,620 bottles of Telmisartan and Amlodipine tablets, a medication used to manage blood pressure. The recall stems from the discovery that certain batches of these tablets are 'superpotent,' meaning they contain higher than specified levels of telmisartan. This issue was identified by the US Food and Drug Administration (FDA). The affected medication is manufactured in India for Viatris, a company based in Morgantown, West Virginia, and is distributed throughout the United States.

The recall, designated as Class III by the FDA, suggests that exposure to the violative product is unlikely to cause adverse health consequences. However, the potential for excessive telmisartan content necessitates the recall. High blood pressure, or hypertension, is a prevalent condition, particularly among older adults, and untreated hypertension can escalate to severe health issues such as heart attacks and strokes.